The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
| Status: | Archived |
|---|---|
| Conditions: | HIV / AIDS, Psychiatric, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Immunology / Infectious Diseases, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2008 |
| End Date: | September 2011 |
HIV drug resistance presents a significant public heath problem. This proposal is designed
to explore the association between ongoing illicit drug use and the prevalence of HIV drug
resistance among HIV+ opioid dependent patients receiving opioid agonist treatment with the
following hypotheses:
1. Hypothesis 1: The prevalence of HIV drug resistance will range between 10% and 30%.
2. Hypothesis 2: Patients with evidence of ongoing illicit drug use will be more likely to
have HIV drug resistance.
We found this trial at
1
site
Click here to add this to my saved trials
